A Review on Cucurbitaceae
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2022, Vol 6, Issue 1
Abstract
Plants are basic source of food and energy cucurbitaceous family possess antibacterial, antimicrobial, antifungal characteristics and showed activities like antioxidant, phytochemical and hypoglycaemic activity. Cucurbitacins which are structurally diverse triterpenes found in the members of Cucurbitaceae and several other plant families possess immense pharmacological potential. The diverse phytoconstituent may prove to be important lead molecules for future research. This review is aimed to provide an insight into the chemical nature and medicinal potential of these compounds.
Authors and Affiliations
Ingle A*, Rathod CP and Shendarkar GR
Keywords
Related Articles
- EP ID EP748605
- DOI 10.23880/oajpr-16000262
- Views 60
- Downloads 0
Covid Cure in the Light of Diet: Eating Habits
People those who eat nutritious and a well-balanced diet will possess a strong immune systems along with low incidence of chronic and infectious diseases. People with chronic disease would have the possibility to get in...
A Glance on Lemon Grass-Extraction, Applications and Uses
Lemongrass is widely available herb belonging to family Poaceae having biological souse leaf of plant Cymbopogon Citratus. The name Lemon originates from its typical odour, because of presence of citral a cyclic monoter...
Tamoxifen: Pharmacokinetics and Pharmacodynamics
Tamoxifen is the hormone therapy of choice in pre-menopausal estrogen receptor positive breast cancer in women and sometimes in post-menopausal women. The environmental and genetic factors widely affect the pharmacokinet...
To Study the Effect of Swertiamarin in Animal Model of Huntington’s Disease
Objective: The Data suggest that swertiamarin has antioxidant activity and they modulate neurotoxicity induced oxidative impairments in the brain and can be effectively employed as a neuroprotective. The preclinical find...
On Rational Design of Precision Drugs
The rational design of perfect precision drugs must be based on a precise definition of the disease’s molecular target. This article offers a perspective on how the current drug development process needs to change to re...